View Online Corporate Workshops (OCWs) are free for all attendees. They are a year-round extension of the popular Corporate Workshops presented each year at the AMP Annual Meeting. They are free to the public and therefore are valuable opportunities for everyone to learn to learn from industry representatives and scientific experts about the latest advances and instrumentation relevant to molecular diagnostics and research. OCWs are presented on weekday afternoons for one hour, and are conducted by commercial companies. Upcoming OCWs will be announced to AMP members on CHAMP, including registration information, as well as posted on this webpage.
Comprehensive Genomic Testing and Targeted Therapies in NSCLC and Thyroid Cancer Patients with Gene Fusions
Speakers:
James Solomon, MD, PhD
Assistant Professor
Department of Pathology and Laboratory Medicine
Weill Cornell Medical College
Shivaani Kummar, MD, FACP
Professor of Medicine and Chief
Division of Hematology and Medical Oncology
Oregon Health and Science University
Access is available for a limited time. There is no fee or membership requirement to access archived OCWs.
Genomic Profiling of Haematological Malignancies using Archer NGS Panels - the HSL Experience
Speaker:
Robert Baker, BSc, MSc
Molecular Haematology Operations Manager
Health Service Laboratories
Moderator:
Elina Wegner, BSc, MSc
Director, Custom NGS Products
Integrated DNA Technologies
Innovations in MRD Detection: Leveraging NGS to Gain Insights into Multiple Myeloma and B-ALL
Speakers:
Roisin McAvera, BSc (Hons), PhD
Multiple Myeloma Research Group
Royal College of Surgeons in Ireland
Prof. Myungshin Kim
Dept. Laboratory Medicine, College of Medicine
The Catholic University of Korea
Moderator:
Parth Sitlani
Associate Director, Commercial EMEA/APAC
Invivoscribe, Inc.
Handouts:
Level Up Your MRD Testing: Leveraging Standardized & Sensitive AML Assessments
Speakers:
Speakers: Tony Sanchez, M.D.
Technical Account Manager
Josh Wemmer, M.S.
Sr. Bioinformatician
Comprehensive Genomic Testing and Targeted Therapies in NSCLC and Thyroid Cancer Patients with Gene Fusions
Speakers:
Lori Wirth, MD
Medical Director, Center for Head and Neck Cancers
Massachusetts General Hospital
Carlo Bifulco, MD
Chief Medical Officer
Providence Genomics
This Corporate Workshop is also supported by Bayer.
Comprehensive, Reliable Answers for Heme Malignancies with Customized Archer™ NGS assays
Speakers:
Barbara Anderson, PhD, MB (ASCP)CM
Analytical Specialist
Division of Molecular Pathology, Genetics and Genomics
Duke University Health System
Ludmila Francescatto, PhD
Laboratory Genetics & Genomics Fellow
Division of Molecular Pathology, Genetics and Genomics
Duke University Health System
NGS Assessment of SHM in CLL/SLL: A Practical Comparison of Platforms & Primers
Speaker:
Kseniya Petrova-Drus, MD, PhD
Assistant Attending Pathologist
Hematopathology and Diagnostic Molecular Pathology
Memorial Sloan Kettering
Diverse Data Matters: Implementing a Simple Yet Comprehensive PCR/CE Based CFTR Kit
Speaker:
Andrea Ferreira-Gonzalez, PhD HCLD(ABB), CC(ABB), FACC
Professor and Chair, Division Molecular Diagnostics
Director, Molecular Diagnostics Laboratory
Virginia Commonwealth University
Moderator:
Ninad Pendsé, MS, MBA
Senior Product Manager
Asuragen, a Bio-Techne Brand
Lab Secrets: NGS-based MRD Testing for Acute Lymphoblastic Leukemia - the Austin Experience
Rishu Agarwal, MBBS PhD FRCPA
Molecular Haematologist
Austin Health & Peter MacCallum Cancer Center
Melbourne, Australia
Stephen B. Ma, BbiomedSc BSc(Hon) MD DipMus LMusA(dist)
Laboratory Haematology Registrar
Austin Health
Melbourne, Australia
Xerna TME™ Panel: An RNA-Based Investigational Assay Designed to Predict Patient Response to Anti-Angiogenic and Immune Targeted Therapies
Speaker:
Mark Uhlik
Vice President, Head of Research & Biomarker Discovery
OncXerna Therapeutics
Faster, simpler, more efficient: The latest improvements in NGS workflows for targeted DNA sequencing
Speakers:
Krishna Amin
Senior Global Product Manager, Targeted NGS
QIAGEN
Sophie Fiola
Field Application Scientist, Clinical Customers
QIAGEN Diagnostics
Precision Medicine: Exon 20 Marks the Spot - EGFR Exon 20 Mutations in Non-Small Cell Lung Cancer (NSCLC)
Speakers:
Hatim Husain, MD
Associate Professor of Medicine
University of California, Moores Cancer Center
Eric Vail, MD
Director, Molecular Pathology
Assistant Professor, Pathology & Laboratory Medicine
Cedars-Sinai Medical Center
Medicare Coverage of Next Generation Sequencing: Pulling Back the Curtain on the What, Why, & How of Medicare Coverage Testing
Speaker:
Gabriel Bien-Willner, MD, PhD, FCAP
Medical Director of MolDX
Chief Medical Officer, Palmetto GBA
Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS)
Speakers:
Riccardo Bomben, MD
Clinical & Experimental Onco-Hematology Unit
IRCCS CRO Aviano, Italy
Wouter De Brouwer, MD
Vrije Universiteit Brussel (VUB)
Universitaire Ziekenhuis Brussel
Department of Hematology
Brussels, Belgium
Handouts:
Invivoscribe MRD Software
Invivoscribe Study of MRD
Lympho Track - MiSeq Workflow
Lympho Track S5PGM Workflow
EGFR Exon 20 Insertions: Distinct EGFR Mutations in NSCLC with Practical Application
Speakers:
Dr. Michelle Shiller, DO, MSPT
Co-Medical Director, Cancer Genetics
Baylor University Medical Center
Dr. Tarek Mekhail, MD
Medical Director, Thoracic Cancer Program
AdventHealth Cancer Institute
Practical and Reliable CFTR Variant Detection for Diverse Populations with the AmplideX® PCR/CE CFTR Kit
Speaker:
John Milligan, PhD
Senior Manager, R&D, Asuragen
Explore the Benefits, Considerations, and Utility of NGS B- and T-cell Clonality Testing
Speakers:
B. Melody Zhang, MD, MS, FCAP, A(ACHI)
Stanford University, School of Medicine
Bijal A Parikh, MD, PhD
Washington University School of Medicine
IDT GMP and OEM Capabilities
Speakers:
Mitch Gore
Commercial & Technical Manager for the B2B, qPCR, and Custom Oligo Product Lines
IDT
Renee Rathjen
GMP Product Manager
IDT
Ultra-sensitive NGS-based Liquid Biopsy Technology in Companion Diagnostics
Speakers:
Frederick S. Jones, PhD
Senior Director, Life Science Medical Affairs
Sysmex Inostics
Johannes Fredebohm, PhD
Head of Research and Innovation
Sysmex Inostics
Dr. Reinhard Ortmann
Director Companion Diagnostics
QIAGEN
The COVID-19 Challenge: The Diagnostic Laboratory Experience
Speakers:
Heba Mostafa, MD, PhD
Johns Hopkins
Jason Ong
Senior Director Marketing, NeuMoDx
KRAS G12C - A Key Emerging Biomarker in the Pathogenic Evaluation of NSCLC
Speaker:
Pranil K. Chandra, DO, FCAP, FASCP
Chief Medical Officer of Genomic and Clinical Pathology
Pathgroup
Testing Methodologies for Optimal Identification of Rare Fusion Events
Speaker:
Susan Hsiao, MD, PhD
Assistant Professor of Pathology & Cell Biology
Columbia University
A Multidisciplinary Approach for Patients with Resectable NSCLC
Speaker:
Shirley Michelle Shiller, DO, MSPT
Co-Director, Medical Genetics; Staff Pathologist
Baylor Sammons Cancer Center, Baylor University Medical Center
Dallas, TX
Translatability of Tumor Inflammation Gene Signatures & Blood-Based Biomarkers of Immuno-Oncology
Speakers:
Nancy Zhang, MD
Associate Director, Pharmacodiagnostics and Precision Medicine, BMS
Jonathan Baden
Senior Director Pharmacodiagnostic, BMS
Treating Late Stage Cancer Patients During a Pandemic: An International and Multidisciplinary Perspective
Presenters:
David Huntsman, MD, FRCPC, FCCMG
Chew Wei Memorial Professor of Gynaecologc Oncology,
Professor: Departments of Pathology and Laboratory Medicine and Obstetrics and Gynaecology: UBC (CANADA)
William G. Morice, II, M.D., Ph.D.
Chair of the Department of Laboratory Medicine and Pathology
President of Mayo Labs Rochester, MN, (U.S.A)
Joerg Kriegsmann
Medical Director of Sonic Germany, aka Molecular Pathologie Trier, (GERMANY)
Rosalyn Juergens, B.S. (Hons), MD., PhD
Associate Professor, Department of Oncology, McMaster University
Adjunct Assistant Professor, Department of Oncology, The Johns Hopkins Medical Institute (CANADA).
Liquid Biopsy Testing Strategies for Patients with Metastatic NSCLC
Presenter:
John W. Longshore, PhD, FACMG
Director, Molecular Pathology Laboratory
Atrium Health, formerly Carolinas HealthCare System
Carolinas Pathology Group
Charlotte, North Carolina
Tackling COVID-19 through Syndromic Testing – QIAstat-Dx Respiratory SARS-CoV-2 Panel
Presenter:
Davide Manissero, MD, MRCPCH, MSc, DTM&H
VP, Head of Medical Affairs & Chief Medical Officer
Infection & Immune Diagnostics, QIAGEN
View Now
Molecular Testing for Alterations in DNA Damage Repair Pathway Genes in Ovarian & Prostate Cancer: Why, Who, & How to Test
Presenter:
Samuel Caughron, MD, FCAP
Pathologist, President & CEO, MAWD Pathology Group
Chair of Pathology & Medical Director of Clinical Laboratory, Advent Health Kansas City
View Now
Learn how to implement a streamlined, single NGS workflow for the analysis of DNA and RNA – all from a single sample
Presenter:
Sylvia Herold, PhD
Institut für Pathologie
Universitätsklinikum Dresden
View Now
Current and Emerging Biomarkers: Science, Technology, & Practicalities
Presenter:
Tabetha Sundin, PhD, HCLD (ABB), MB(ASCP)
Scientific Director
Molecular Diagnostics & Serology
Sentara Healthcare
View Now
Utility of NGS Assays for the Evaluation of Lymphoid Malignancies
Presenters:
Yury Monczak, PhD, Scientific Co-Director, Molecular Pathology Center, McGill University Health Center, Jewish General Hospital, Assistant Professor, McGill University
Bevan Tandon MD, Director, Cancer Genomics, BioReference Laboratories, an OPKO Health Company
View Now
New Tools to Overcome Challenges in Vaginitis Diagnosis and Treatment
Presenter: Jane Schwebke, MD, Professor of Medicine – Infectious Disease Division, University of Alabama - Birmingham
View Now
The Power of ONE: Introducing a Novel 1-Day Workflow for Simultaneous High-Sensitivity Analysis of DNA Variants & RNA Fusions
Presenter:Jonathan Shaffer, PhD, MBA, Associate Director, NGS Assay Research & Development, QIAGEN
View Now
Experience the Power of ONE: Simultaneous Detection of DNA Variants & RNA Fusions in 1-Day Workflow from Sample to Sequencing
Presenters:
George J. Quellhorst, Jr., PhD Associate Director, R&D, QIAGEN;
Andrew Cassidy, PhD, Marketing Project Manager, Enterprise Genomic Services, QIAGEN
View Now
Implementation of a Cost-Effective NGS Program in a Laboratory with Limited Resources.
Presenters:
Yassmine Akkari, PhD, Legacy Health
Eva Szarek, PhD, QIAGEN
View Now
Minimal Residual Disease Detection of B-lymphoid and Plasma Cell Neoplasm Using a NGS-Based Clonal IGH Rearrangement Assay
Presenters:
Caleb Ho, MD Memorial Sloan Kettering Cancer Center
Ryan Schmidt, MD, PhD, University of Southern California/Children’s Hospital, Los Angeles
View Now
A Pathologist's Guide to Companion Diagnostics and Precision Medicine in Oncology
Presenters: Anjen Chenn, MD, PhD, Sr Director Molecular Diagnostics, LabCorp
Jennifer Quigley, Director Oncology Product Commercialization, LabCorp – Integrated Oncology
Benjamin Chaffey, PhD, Global Product Manager, QIAGEN
View Now
Syndromic Respiratory Testing in a Dynamic Reimbursement Landscape
Presenters:
James Dunn, PhD,Director, Medical Microbiology & Virology Lab, Texas Children’s & Baylor Hospitals
Paul Radensky, MD, JD, Principal, McDermott Consulting
View Now
Pathology Leadership in Biomarker Testing: Pre-Analytical Phase
Presenter: Michelle Shiller, DO, Baylor University Medical Center
View Now
Mutational Signatures in Cytogenetics Risk Groups of Newly Diagnosed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Presenter: Robyn Sussman, PhD, Hospital of the University of Pennsylvania
Moderator: Jung Doh, PhD, Beckman Coulter Life Sciences
View Now
Handout (PDF)
Why Liquid Biopsy is Important in Clinical Routine...
Presenter: Ron van Schaik
Rotterdam, The Netherlands
View Now
ALK-EML4 Fusions in ctDNA of Lung Cancer Patients in Clinical Practice
Presenter: Antoinette Lemoine
Paris, France
View Now
Complete Suite of NGS Clonality Assays with Bioinformatics - Identification and Tracking Patient-specific Clones
Presenters: Presha Shah, PhD and Kasey Hutt, PhD
Invivoscribe, San Diego, CA
View Now
Handout
LymphoTrack Portfolio - MiSeq
LymphoTrack Portfolio - Ion PGM
Mycoplasma genitalium Infection: An Emerging Sexually Transmitted Infection
Presenter: William M. Geisler MD, MPH
University of Alabama at Birmingham
View Now
Handout
NGS Clonality Testing: Assessing Clonality Status, Somatic Hypermutation and Monitoring Minimum Residual Disease (MRD)
Presenter: Maria Arcila, MD
Moderator: Jeff Miller, PhD
View Now
Handout
Challenges in Genomic Aberration Detection and Interpretation in Solid Tumors and Evidence-based Approaches for Targeted Therapy
Presenters: Nevenka Dimitrova, PhD and Sheryl Elkin, PhD
Moderator: Autri Dutta, PhD
View Now
Handout
Genetics in Clinical Diagnostics
Presenter: Michael Snyder, PhD
Moderator: Nevenka Dimitrova, PhD
View Now (Audio starts at 1:15)
Handout
Monitoring Deep Molecular Response: A Sensitive and Robust FDA Cleared Assay for CML
Presenters: Bernard F. Andruss, PhD and Y. Lynn Wang, MD, PhD, FCAP
Moderator: Ninad Pendsé, MBA
View Now
Comprehensive Tumor Characterization Using Augmented NGS
Presenter: Christelle Johnson, PhD
Moderator: Erin Newburn, PhD
View Now
Achieving High Diagnostic Yield for Clinically Relevant Genes: How to ‘ACE' Exome Sequencing
Presenter: Heather Wetzel, MS, LCGC
Moderator: Felicia Hawthorne, PhD
View Now
Diamond Partner
Silver Partner
Silver Partner
Platinum Partner
Silver Partner
Gold Partner
Silver Partner
Gold Partner
Gold Partner
Gold Partner
Gold Partner
Gold Partner
Gold Partner
Silver Partner
Gold Partner
Diamond Partner
Gold Partner
Platinum Partner
Silver Partner